Keros Therapeutics Inc (KROS)
58.12
-0.56
(-0.95%)
USD |
NASDAQ |
May 08, 16:00
58.12
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Profit Margin (Quarterly): -28.14K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -28.14K% |
| September 30, 2023 | -493.0K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -34.70% |
| September 30, 2021 |
| Date | Value |
|---|---|
| June 30, 2021 | -15.62K% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -110.0% |
| September 30, 2019 | -142.0% |
| June 30, 2019 | -114.1% |
| March 31, 2019 | -127.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-493.0K%
Minimum
Sep 2023
-34.70%
Maximum
Dec 2021
-76.74K%
Average
-142.0%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 22.96% |
| Scholar Rock Holding Corp | -- |
| Morphic Holding Inc | -- |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.21% |
| Return on Assets | -43.87% |
| Return on Invested Capital | -48.21% |
| Operating Margin (Quarterly) | -30.81K% |
| Return on Net Operating Assets | -495.3% |